| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |